Summary
Preeclampsia is a life-threatening pregnancy disorder. However, its pathogenesis remains unclear. We tested the hypothesis that gestational hypoxia induces preeclampsia-like symptoms via heightened endothelin-1 signaling. Time-dated pregnant and non-pregnant rats were divided into normoxic and hypoxic (10.5% O2 from the gestational day 6 to 21) groups. Chronic hypoxia had no significant effect on blood pressure or proteinuria in non-pregnant rats but significantly increased blood pressure in day 12 (systolic blood pressure: 111.7 ± 6.1 versus 138.5 ± 3.5 mmHg, P = 0.004) and day 20 (systolic blood pressure: 103.4 ± 4.6 versus 125.1 ± 6.1 mmHg, P = 0.02) in pregnant rats, as well as urine protein (μg/μL)/creatinine (nmol/μL) ratio in day 20 (0.10 ± 0.01 versus 0.20 ± 0.04, P = 0.04), as compared with the normoxic control group. This was accompanied with asymmetrical fetal growth restriction. Hypoxia resulted in impaired trophoblast invasion and uteroplacental vascular remodeling. In addition, plasma endothelin-1 levels, as well as the abundance of prepro-endothelin-1 mRNA, endothelin-1 type A receptor and angiotensin II type 1 receptor protein in the kidney and placenta were significantly increased in the chronic hypoxic group, as compared with the control animals. Treatment with the endothelin-1 type A receptor antagonist, BQ123 during the course of hypoxia exposure significantly attenuated the hypoxia-induced hypertension and other preeclampsia-like features. The results demonstrate that chronic hypoxia during gestation induces preeclamptic symptoms in pregnant rats via heightened endothelin-1 and endothelin-1 type A receptor-mediated signaling, providing a molecular mechanism linking gestational hypoxia and increased risk of preeclampsia.